ACUR — Acura Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $0.16m
- $1.56m
Brief: Acura Pharmaceuticals qtrly loss per share $0.28
Brief: Acura's Limitx technology successfully confirms oral abuse deterrence capabilities
Brief: Acura Pharmaceuticals reports Q1 net loss $0.28 per diluted share
Brief: Acura Pharmaceutical's Limitx technology successfully demonstrates oral abuse deterrence
Brief: Acura Pharmaceuticals came to co's attention it previously inadvertently disclosed to an analyst information not previously publicly disclosed by co
Reuters Insider - Politics: Apple vs. FBI
Brief: Acura Pharmaceuticals reports Q4 loss of $0.08/shr
Reuters Insider - Davos Today: Saturday 2016
Brief: Acura Pharmaceuticals says advancing limitx into clinical testing
FDA delays ruling on Collegium's opioid painkiller (updated)
Brief: Acura gets $2.5 mln milestone payment from Egalet Corp
Collegium's painkiller gets green light from FDA panel (updated)
Brief: Egalet Corporation launches Acura pharmaceuticals' Oxaydo
Brief: Acura Pharma announces 1-for-5 reverse stock split
Brief: Acura Pharmaceuticals qtrly loss per share $0.05
Brief: Acura Pharmaceuticals to raise approximately $7.6 mln
Brief: Acura Pharmaceuticals, Mlv & Co terminate market issuance sales agreement
Brief: Acura Pharmaceuticals eligible to get reimbursement of development costs, royalties in connection with Bayer Healthcare agreement
Brief: Acura Pharmaceuticals enters license, development agreement with Bayer Healthcare